Cortisol Awakening Response Is Linked to Disease Course and Progression in Multiple Sclerosis
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Dysregulation of the hypothalamus-pituitary-adrenal (HPA) axis has frequently been reported in multiple sclerosis (MS). So far, HPA axis function in MS has predominantly been studied under pharmacological stimulation which is associated with a series of methodological caveats. Knowledge of circadian cortisol patterns and cortisol awakening response (CAR) is still limited. METHODS: A total of 77 MS patients (55 relapsing-remitting MS (RRMS)/22 secondary-progressive MS (SPMS)) as well as 34 healthy control (HC) subjects were enrolled. Diurnal cortisol release was assessed by repeated salivary cortisol sampling. Neurological disability was rated by the Kurtzke's Expanded Disability Status Scale (EDSS). Depressive symptoms and perceived stress were assessed by self-report measures. RESULTS: RRMS but not SPMS patients differed in circadian cortisol release from HC subjects. Differences in cortisol release were restricted to CAR. Treated and treatment naïve RRMS patients did not differ in CAR. In a RRMS follow-up cohort (nine months follow-up), RRMS patients with EDSS progression (≥0.5) expressed a significantly greater CAR compared to HC subjects. RRMS patients with a stable EDSS did not differ from HC subjects. Neither depressive symptoms nor perceived stress ratings were associated with CAR in RRMS patients. In a step-wise regression analysis, EDSS at baseline and CAR were predictive of EDSS at follow-up (R(2) = 67%) for RRMS patients. CONCLUSIONS: Circadian cortisol release, in particular CAR, shows a course specific pattern with most pronounced release in RRMS. There is also some evidence for greater CAR in RRMS patients with EDSS progression. As a consequence, CAR might be of predictive value in terms of neurological disability in RRMS patients. The possible role of neuroendocrine-immune interactions in MS pathogenesis is further discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which is impaired in individuals with UMNDs such as MS, BI, stroke, and SCI.46–50”
From Feasibility, Acceptability, and Efficacy of Mindfulness Training in People With Upper Motor Neuron Disorders: A Systematic Review (2022) · cites this paper as [46]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267 · cited 3×
“Neurological disability was rated by the Kurtzke’s Expanded Disability Status Scale (EDSS).”
MethodRating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011 · cited 1×
“For MS patients, neurological impairment was rated using Kurtzke’s Expanded Disability Status Scale (EDSS) [21] based on the Neurostatus scoring system (www.”
MethodDiagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20703 · Cited by 5,017 · cited 1×
“Eighty-six patients with definite MS according to revised McDonald criteria [20] as well as thirty-seven HC subjects were enrolled.”
MethodCompston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Pruessner, J. C., Kirschbaum, C., Meinlschmid, G., & Hellhammer, D. H. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00108-7 · Cited by 3,638 · cited 1×
“For CAR (samples 1–4), an area under the curve with respect to ground (AUCawakening) was calculated as previously described [25].”
MethodThe cortisol awakening response (CAR): Facts and future directions
Fries, E., Dettenborn, L., & Kirschbaum, C. (2009) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2008.03.014 · Cited by 1,188 · cited 1×
“The cortisol awakening response (CAR) is a well described phenomenon which is characterized by a pronounced increase of cortisol within 20 to 30 minutes after awakening [1,2].”
BackgroundCortisol awakening response and psychosocial factors: a systematic review and meta-analysis
Chida, Y., & Steptoe, A. (2009) · Biological Psychology · doi:10.1016/j.biopsycho.2008.10.004 · Cited by 1,032 · cited 1×
“The cortisol awakening response (CAR) is a well described phenomenon which is characterized by a pronounced increase of cortisol within 20 to 30 minutes after awakening [1,2].”
BackgroundMajor depressive disorder and hypothalamic-pituitary-adrenal axis activity
Vreeburg, S. A., Hoogendijk, W. J. G., van Pelt, J., DeRijk, R. H., Verhagen, J. C. M., van Dyck, R., Smit, J. H., Zitman, F. G., & Penninx, B. W. J. H. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.50 · Cited by 792 · cited 1×
“It is further modulated by various factors such as genetic polymorphisms [5], stressful experience [5,6,7], affective symptoms [6,8] and inflammatory states [9].”
BackgroundGenetic factors, perceived chronic stress, and the free cortisol response to awakening
Wüst, S., Federenko, I., Hellhammer, D. H., & Kirschbaum, C. (2000) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(00)00021-4 · Cited by 642 · cited 1×
“It is further modulated by various factors such as genetic polymorphisms [5], stressful experience [5,6,7], affective symptoms [6,8] and inflammatory states [9].”
BackgroundGlucocorticoids and the Th1/Th2 Balance
ELENKOV, I. J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.010 · Cited by 612
Research works printed but not linked: 1
- Schulz P, Schlotz W (1999) The Trier Inventory for Chronic Stress (TICS): scale construction, statistical testing and validation of the scale work overload. Diagnostica 45: 8– 19.
Cited by
Wahl, M., Buchholz, B., Winde, V., Golomb, D., Guy‐Haim, T., Müller, J. D., Rilov, G., Scotti, M., & Böttcher, M. E. (2015) · Limnology and Oceanography Methods · doi:10.1002/lom3.10055 · Cited by 101
Steptoe, A., & Serwinski, B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800951-2.00034-0 · Cited by 91
Morris, G., Reiche, E. M. V., Murru, A., Carvalho, A. F., Maes, M. H. J., Berk, M., & Puri, B. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0843-5 · Cited by 79
Thomas, N., Gurvich, C., Huang, K., Gooley, P. R., & Armstrong, C. W. (2022) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2022.100995 · Cited by 80
Biernacki, T., Kokas, Z., Sandi, D., Füvesi, J., Fricska‐Nagy, Z., Faragó, P., Kincses, Z. T., Klivènyi, P., Bencsik, K., & Vécsei, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063383 · Cited by 53
Circadian cortisol and fatigue severity in relapsing-remitting multiple sclerosis
Powell, D. J. H., Moss-Morris, R., Liossi, C., & Schlotz, W. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.03.010 · Cited by 48
Pereira, G. M., Soares, N. M., Rysdyk, A., Becker, J., Finkelsztejn, A., & de Almeida, R. M. M. (2018) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20180091 · Cited by 39
Potential Circadian Rhythms in Oligodendrocytes? Working Together Through Time
Colwell, C. S., & Ghiani, C. A. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02778-5 · Cited by 33
Jarvis, K., Richter, S. M., & Vallianatos, H. (2017) · Midwifery · doi:10.1016/j.midw.2017.03.013 · Cited by 30
Stress-Axis Regulation by Vitamin D3 in Multiple Sclerosis
Rolf, L., Damoiseaux, J., Huitinga, I., Kimenai, D., van den Ouweland, J., Hupperts, R., & Smolders, J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00263 · Cited by 28
“Intriguingly, increased CAR in RRMS has been associated with increased disability progression (16), which makes this a relevant outcome to be suppressed by vitamin D3 supplements.”
BackgroundInfluentialIndividual differences in glucocorticoid regulation: Does it relate to disease risk and resilience?
Caulfield, J. I., & Cavigelli, S. A. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100803 · Cited by 28
“Secondary-progressive multiple sclerosis patients demonstrated significant associations between CAR AUC and neurological impairments (Kern et al., 2013).”
BackgroundTrabjerg, M. S., Mørkholt, A. S., Lichota, J., Oklinski, M. K., Andersen, D. C., Jønsson, K., Mørk, K., Skjønnemand, M.-L. N., Kroese, L. J., Pritchard, C. E. J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-72638-8 · Cited by 32
Neuroprotective Benefits of Antidepressants in Multiple Sclerosis: Are We Missing the Mark?
Grech, L., Butler, E. G., STUCKEY, S. L., & Hester, R. (2019) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.18070164 · Cited by 29
Time matters – Acute stress response and glucocorticoid sensitivity in early multiple sclerosis
Kern, S., Rohleder, N., Eisenhofer, G., Lange, J., & Ziemssen, T. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.04.006 · Cited by 25
Self-citationMultiple sclerosis and circadian rhythms: Can diet act as a treatment?
Pivovarova‐Ramich, O., Zimmermann, H. G., & Paul, F. (2023) · Acta Physiologica · doi:10.1111/apha.13939 · Cited by 27
“115 Notably, glucocorticoids are also involved in regulating energy metabolism and immune reactions and demonstrated altered rhythmicity in the animal model of MS. 102 In the same model, leptin, a metabolic hormone secreted by adipose tissue and regulating energy homeostasis, satiety,…”
BackgroundChronobiological regulation of psychosocial and physiological outcomes in multiple sclerosis
Somma, E. D., Jain, R. W., Poon, K. W. C., Tresidder, K. A., Segal, J. P., & Ghasemlou, N. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.011 · Cited by 22
“The effect of circadian cortisol on disease course and disability has been investigated in MS, with studies noting an association between higher CAR and EDSS score (Kern et al., 2013, 2011).”
InfluentialLi, H., Chen, K., Yang, L., Wang, Q.-L., Zhang, J., & He, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1107780 · Cited by 21
“The present study did not find a causal association between plasma cortisol and the risk of developing MS, which is different from many observational studies (80, 81).”
ResultHair cortisol concentration, cognitive, behavioral, and motor impairment in multiple sclerosis
Pereira, G. M., Becker, J., Soares, N. M., de Azeredo, L. A., Grassi‐Oliveira, R., Rysdyk, A., & de Almeida, R. M. M. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02040-w · Cited by 19
Association of copeptin and cortisol in newly diagnosed multiple sclerosis patients
Baranowska-Bik, A., Kochanowski, J., Uchman, D., Litwiniuk, A., Kalisz, M., Martyńska, L., Wolińska‐Witort, E., Baranowska, B., & Bik, W. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.03.011 · Cited by 17
“MS patients are thought to have impaired hypothalamo-pituitary–adrenal axis activity (Kumpfel et al., 2014; Kern et al., 2011, 2013).”
BackgroundMeyer‐Arndt, L., Hetzer, S., Asseyer, S., Bellmann–Strobl, J., Scheel, M., Stellmann, J., Heesen, C., Engel, A. K., Brandt, A. U., Haynes, J., et al. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100244 · Cited by 17
“This finding of a detrimental effect of psychological stress insensitivity for disease processes is compatible with a positive link between HPA-axis activity in pharmacological challenge tasks and future EDSS in pwMS (Gold et al., 2005; Kern et al., 2013).”
BackgroundResultEvangelopoulos, M., Ansari, N. N., Kassi, E. N., Papadopoulou, A., Evangelopoulos, D. S., & Moutsatsou, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-98868-y · Cited by 13
Circadian Clock: A Regulator of Immunity in Autoimmune Diseases
Wu, Y., Zhang, S., Chen, H., He, X., & Yang, G. (2025) · Immunity Inflammation and Disease · doi:10.1002/iid3.70246 · Cited by 14
“An increase in the cortisol awakening response and an increase in cortisol within approximately 30 min after awakening were found, and this change in the cortisol level was found to be associated with neurological disability worsening and fatigue [156 – 158].”
Brasanac, J., Hetzer, S., Asseyer, S., Kuchling, J., Bellmann–Strobl, J., Ritter, K., Gamradt, S., Scheel, M., Haynes, J., Brandt, A. U., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac086 · Cited by 12
“For example, our study did not comprise secondaryprogressive MS patients—and cross-sectional associations between EDSS and salivary cortisol were restricted to such patients.(63) Having said that, our analyses are in linewith previous findings of (i) a differential link between cortisol and brain activity across group…”
ResultRelation between cognitive fatigue and circadian or stress related cortisol levels in MS patients
Hildebrandt, H., Stachowiak, R., Heber, I. A., Schlake, H.-P., & Eling, P. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102440 · Cited by 12
Volumetric changes in hypothalamic subunits in patients with relapsing remitting multiple sclerosis
Genç, B., Şen, S., Aslan, K., & İncesu, L. (2023) · Neuroradiology · doi:10.1007/s00234-023-03122-z · Cited by 12
“HPA axis activity, and MS patients have high basal cortisol levels [31].”
BackgroundMeyer‐Arndt, L., Schmitz‐Hübsch, T., Bellmann–Strobl, J., Brandt, A. U., Haynes, J., Gold, S. M., Paul, F., & Weygandt, M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.753107 · Cited by 10
“(54), and with findings showing that stronger cortisol awakening responses in PwMS are associated with worse EDSS 9 months later (16).”
BackgroundPropp, M. A., Paz, D. C., Makhkamov, S., Payton, M. E., Choudhury, Q. G., Nutter, M., & Ryznar, R. J. (2024) · Biomedicines · doi:10.3390/biomedicines12112519 · Cited by 9
Razia, R., Majeed, F., Amin, R., Mukhtar, S. M., Mehmood, K., & Baig, D. N. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.05.002 · Cited by 9
Korupolu, R., Malik, A., Ratcliff, C., Robinson-Whelen, S., & Taylor, H. B. (2022) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2022.05.020 · Cited by 8
Altered Steroidome in Women with Multiple Sclerosis
Kancheva, R. L., Hill, M., Velíková, M., Kancheva, L. S., Včelák, J., Ampapa, R., Židó, M., Štětkářová, I., Libertínová, J., Vosátková, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212033 · Cited by 9
“The C19 Δ 5 by data from Kern et al. reporting an increasing cortisol awakening response in MS patients with increasing disability over the course of the disease [76].”
The stress-axis in multiple sclerosis: Clinical, cellular, and molecular aspects
Melief, J., Huitinga, I., & Gold, S. M. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-820683-6.00008-7 · Cited by 9
Role of Socioeconomic Position in Multiple Sclerosis Etiology
Briggs, F. B. S., Green, M. C., & Weintraub, M. R. (2015) · Neurodegenerative Disease Management · doi:10.2217/nmt.15.22 · Cited by 9
Plasma copeptin levels in patients with multiple sclerosis
Köseoğlu, M., Özben, S., Gozubatik‐Celik, G., Tütüncü, M., Küçüksayan, E., Hanikoglu, A., Ataklı, D., & Özben, T. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.04.095 · Cited by 6
Arata, M. A., & Sternberg, Z. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1547235 · Cited by 5
Abe, J., Jafarpour, S., Vu, M. H., O’Brien, D., Boyd, N. K., Vogel, B. N., Nguyen, L., Paulsen, K. C., Saucier, L. E., Ahsan, N., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1304610 · Cited by 4
Mokary, Y., Vaheb, S., Panah, M. Y., Afshari-Safavi, A., Ghaffary, E. M., Barzegar, M., Shirbacheh, A., Shaygannejad, V., & Mirmosayyeb, O. (2024) · Acta Neurologica Scandinavica · doi:10.1155/2024/8728071 · Cited by 4
“In addition, Kern et al. revealed that the cortisol awakening response was not associated with depressive symptoms [38].”
Predictors of milk cortisol in North American women
Anyim, R., Li, S., Armstrong, D., Spathis, R., James, G. D., Little, M. A., & Wander, K. (2023) · American Journal of Human Biology · doi:10.1002/ajhb.23985 · Cited by 4
“We also considered maternal and child illness as potential sources of maternal stress (e.g., individuals with multiple sclerosis exhibit patterns indicative of higher stress) (Kern et al., 2013).”
BackgroundGoischke, H.-K. (2023) · Exploration of neuroscience · doi:10.37349/en.2023.00020 · Cited by 6
Janse, M., van Faassen, M. H. J. R., Kema, I., Smink, A., Ranchor, A. V., Fleer, J., & Sprangers, M. A. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135708 · Cited by 3
“Indeed, worries and daily stressors, like goal disturbance after cancer diagnosis, have been linked to steeper Cortisol Awakening Responses (CAR, increase in cortisol between awakening and 30–45 minutes later) [12–17] and flattened Diurnal Cortisol Slopes (DCS, decrease in cortisol between 30–45 minutes after awakenin…”
BackgroundAmbulatory Assessment in Neuropsychology: Applications in Multiple Sclerosis Research
Schlotz, W., & Powell, D. (2014) · Zeitschrift für Neuropsychologie · doi:10.1024/1016-264x/a000140 · Cited by 2
“Although the cortisol awakening responses (CAR) in daily life was found to be increased and associated with worsening of disability status in RRMS, it was not related to perceived stress (Kern et al., 2013).”
BackgroundImmunopathology and Pathogenesis
Zettl, U. K., & Patejdl, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-13498-2_4 · Cited by 1
Scheffer, M., Rebelo, F. D. C., Pereira, G. M., & de Almeida, R. M. M. (2018) · Revista Neuropsicologia Latinoamericana · doi:10.5579/rnl.2018.0425 · Cited by 2
Determinants of Depression in Multiple Sclerosis
Berzins, S. A. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.5072/prism/25602
Neuroimmune Regulation in Health and Disease
Berczi, I. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801770-8.00001-x
Use of Facebook as a Social Support System to Maintain an Individual's Resource Pool
Fontaine, M. (2018) · ScholarWorks (Walden University) · Cited by 1
Inflammatory Conditions of the Hypothalamus
Lovera, J. F., Feria, O. V., & Losada, V. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-030-62187-2_20
Evangelopoulos, M., Ansari, N. N., Kassi, E. N., Papadopoulou, A., Evangelopoulos, D. S., & Moutsatsou, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-02415-8
The neuroimmunology of fatigue in multiple sclerosis
Ayache, S. S., & Chalah, M. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18578-6.00004-0
Malakhov, V., & Гапонов, П. (2021) · Psychosomatic Medicine and General Practice · doi:10.26766/pmgp.v6i1.305
A Decade of Hypnotherapy Research for Multiple Sclerosis Symptom Management: A Systematic Review
Özdemir, A. O., Cozzolino, M., Gürdal, O., Arcangeli, I. C., Mancone, S., & Celia, G. (2025) · The American Journal of Medicine · doi:10.1016/j.amjmed.2025.05.049 · Cited by 1
Neuro-immune correlates of stress-related symptoms in multiple sclerosis
Brasanac, J. (2023) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-39625
Hildebrandt, H., & Stuke, H. (2026) · Brain Disorders · doi:10.1016/j.dscb.2026.100318
Arashlow, F. T., Fekri, M., Salarvandian, S., Darfarin, K., Esmaeilpour, K., & Ebrahimi, R. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107247
Cinesi, G., Sperandei, S., Quattrucci, L., Sciolto, A., Emiliano, E., Scopetta, F., Sabatino, E. D., Mancini, A., Gaetani, L., Parnetti, L., et al. (2026) · Chronobiology International · doi:10.1080/07420528.2026.2703128
“Alterations in hypothalamic–pituitary–adrenal (HPA) axis function, including elevated cortisol awakening response, have been documented in MS patients and correlate with depressive symptoms and disease progression (Kern et al. 2013).”
Influência do ritmo circadiano sobre a esclerose múltipla: uma revisão sistemática
Souza, I. M. C., Neto, F. F. L., Mota, G. H. L., Maia, M. N., & de Paula-Júnior, W. (2024) · REVISTA CIENTÍFICA DA FAMINAS
Metadata
- Authors
- Kern, S., Krause, I., Horntrich, A., Thomas, K., Aderhold, J., & Ziemssen, T.
- Affiliations
- University Hospital Carl Gustav Carus (DE)
- Corresponding author
- Kern, Simone
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-04-16
- Volume
- 8
- Issue
- 4
- Pages
- e60647
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3628870
- OpenAlex
- W1996708457
- Semantic Scholar
- 650daa21a1a6da8a0ff90c8548374496fc8e56fc
- Cited by
- 50
- References
- 35
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2023: 8 · 2022: 5 · 2021: 4 · 2020: 5 · 2019: 4 · 2018: 4 · 2017: 1 · 2016: 2 · 2015: 6 · 2014: 3
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Qucosa (Saxon State and University Library Dresden) (submittedVersion, cc-by)
- Funders
- Sanofi
- Biogen
- Teva Pharmaceutical Industries
- Deutsche Forschungsgemeinschaft
- Technische Universität Dresden
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- cortisol awakening response, multiple sclerosis, relapsing-remitting multiple sclerosis, secondary progressive multiple sclerosis, HPA axis dysregulation, disability progression, Expanded Disability Status Scale, depressive symptoms, perceived stress, neuroendocrine-immune interaction
- MeSH terms
- Adult, Female, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Middle Aged, Multiple Sclerosis, Pituitary-Adrenal System, Saliva, Case-Control Studies, Young Adult, Circadian Clocks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.